Journey Medical Submits NDA For DFD-29 To FDA For Treatment Of Rosacea In Adults

RTTNews | il y a 592
Journey Medical Submits NDA For DFD-29 To FDA For Treatment Of Rosacea In Adults

(RTTNews) - Pharmaceutical company Journey Medical Corp. (DERM) announced Friday that the Company has submitted a New Drug Application or NDA, to the U.S. Food and Drug Administration or FDA, seeking approval for DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the treatment of inflammatory lesions and erythema of rosacea in adults.

DFD-29 is being developed in collaboration with Dr. Reddy's Laboratories Ltd. If approved, DFD-29 has potential to be best-in-class and the only oral medication to address both inflammatory lesions and erythema (redness) from rosacea

The NDA submission is supported by positive data from Journey Medical's two DFD-29 Phase 3 clinical trials for the treatment of rosacea.

The Phase 3 clinical trials achieved all co-primary and secondary endpoints, and subjects completed the 16-week treatment with no significant safety issues.

read more
Japan Shares May Extend Tuesday's Losses

Japan Shares May Extend Tuesday's Losses

The Japan stock market on Tuesday ended the two-day winning streak in which it had surged more than 1,120 points or 2.8 percent. The Nikkei 225 now sits just beneath the 43,550-point plateau and the losses may accelerate on Wednesday.
RTTNews | il y a 18 minutes
Tech Shares May Drag South Korea Lower On Wednesday

Tech Shares May Drag South Korea Lower On Wednesday

The South Korea stock market has moved lower in back-to-back sessions, sinking almost 75 points or 2.4 percent along the way. The KOSPI now sits just above the 3,150-point plateau and it may take further damage again on Wednesday.
RTTNews | il y a 33 minutes
New Zealand Rate Decision On Tap For Wednesday

New Zealand Rate Decision On Tap For Wednesday

The Reserve Bank of New Zealand will wrap up its monetary policy meeting on Wednesday and then announce its decision on interest rates, highlighting a busy day for Asia-Pacific economic activity. The RBNZ is expected to trim its Official Cash Rate (OCR) by 25 basis points, to 3.00 percent from 3.25 percent.
RTTNews | il y a 1h 33min
Canadian Market Modestly Lower In Cautious Trade

Canadian Market Modestly Lower In Cautious Trade

After moving modestly higher in early trades, the Canadian market gave up gains as investors digested the nation's inflation data, and closely followed the developments on Russia-Ukraine peace talks front.
RTTNews | il y a 5h 5min
Swiss Market Ends On Strong Note

Swiss Market Ends On Strong Note

After a somewhat subdued start, the Switzerland market gained in strength as the session progressed on Tuesday, to eventually closed on a bright note.
RTTNews | il y a 5h 44min
European Stocks Close Higher On Russia-Ukraine Peace Deal Hopes

European Stocks Close Higher On Russia-Ukraine Peace Deal Hopes

European stocks closed higher on Tuesday as the mood remained positive amid optimism over a potential Russia-Ukraine peace deal, after U.S. President Donald Trump described his meeting with Ukrainian President Volodymyr Zelenskyy and several other European leaders as "very good".
RTTNews | il y a 6h 8min
U.S. Housing Starts Unexpectedly Surge In July But Building Permits Slump

U.S. Housing Starts Unexpectedly Surge In July But Building Permits Slump

A report released by the Commerce Department on Tuesday unexpectedly showed a sharp increase by new residential construction in the U.S. in the month of July. The Commerce Department said housing starts shot up by 5.2 percent to an annual rate of 1.428 million in July after spiking by 5.9 percent to an upwardly revised rate of 1.358 million in June.
RTTNews | il y a 9h 46min